Zentalis Pharmaceuticals, LLC(ZNTL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZNTL Zentalis Pharmaceuticals, LLC

已收盘 11-18 16:00:00 EST

3.05

-0.42

-12.10%

盘后3.03

-0.02-0.66%

19:42 EST

最高3.48	最低3.00	成交量147.12万
今开3.48	昨收3.47	日振幅13.83%
总市值2.17亿	流通市值1.70亿	总股本7,127万
成交额461.81万	换手率2.65%	流通股本5,561万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZNTL","market":"US","secType":"STK","nameCN":"Zentalis Pharmaceuticals, LLC","latestPrice":3.05,"timestamp":1731963600000,"preClose":3.47,"halted":0,"volume":1471249,"hourTrading":{"tag":"盘后","latestPrice":3.03,"preClose":3.05,"latestTime":"19:42 EST","volume":270735,"amount":825743.5822,"timestamp":1731976949701},"delay":0,"floatShares":55606111,"shares":71265400,"eps":-2.526158,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.42,"latestTime":"11-18 16:00:00 EST","open":3.48,"high":3.48,"low":3,"amount":4618093.7758566,"amplitude":0.138329,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.526158,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1585886400000,"adjPreClose":3.47,"preHourTrading":{"tag":"盘前","latestPrice":3.46,"preClose":3.47,"latestTime":"09:29 EST","volume":507,"amount":1753.6326912,"timestamp":1731940199999},"postHourTrading":{"tag":"盘后","latestPrice":3.03,"preClose":3.05,"latestTime":"19:42 EST","volume":270735,"amount":825743.5822,"timestamp":1731976949701},"volumeRatio":0.954397,"impliedVol":1.959,"impliedVolPercentile":0.8685},"requestUrl":"/m/hq/s/ZNTL","defaultTab":"news","newsList":[{"id":"2484167426","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.91%报3.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484167426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484167426?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:53","pubTimestamp":1731941580,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时53分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.91%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为547.20%、409.52%、298.08%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fate Therapeutics, Inc.，振幅分别为118.81%、71.83%、62.38%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822530198e43452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822530198e43452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2483047608","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483047608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483047608?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:33","pubTimestamp":1731594813,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时33分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.10%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422333398e42a20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422333398e42a20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL","ELAB","BK4183"],"gpt_icon":0},{"id":"2483587852","title":"Zentalis 制药公司公布本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483587852","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483587852?lang=zh_cn&edition=full","pubTime":"2024-11-14 04:23","pubTimestamp":1731529429,"startTime":"0","endTime":"0","summary":"Zentalis 制药公司公布本季度业绩 - 收益摘要Zentalis Pharmaceuticals Inc ZNTL.OQ报告本季度调整后每股亏损56美分，高于去年同期的每股-79美分。华尔街预期为每股亏损-99 美分至-81 美分。Zentalis Pharmaceuticals Inc 报告的季度每股收益为亏损 56 美分。该公司当季亏损 4016 万美元。Zentalis Pharmaceuticals Inc 本季度股价上涨了 0.8%，今年迄今为止亏损了 75.5%。华尔街对 Zentalis Pharmaceuticals Inc 的 12 个月目标价中位数为 8.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL4T3MK21T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2483845728","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大涨11.59%报4.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483845728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483845728?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:32","pubTimestamp":1731508353,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时32分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价快速拉升11.59%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Mersana Therapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为329.98%、176.36%、84.76%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Lexeo Therapeutics, Inc.、Mersana Therapeutics, Inc.，振幅分别为14.89%、10.88%、10.27%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322323395be2380&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322323395be2380&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2481100131","title":"Zentalis Pharmaceuticals, Inc.盘中异动 大幅上涨5.25%报4.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481100131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481100131?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:10","pubTimestamp":1731078636,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时10分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.25%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108231037abae538b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108231037abae538b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2481180390","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.08%报4.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481180390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481180390?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:50","pubTimestamp":1730994653,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时50分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.08%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Celularity Inc.涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为769.54%、172.79%、95.44%，振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.，振幅分别为84.83%、68.89%、57.79%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107235053a22115b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107235053a22115b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2481988810","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.29%报3.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481988810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481988810?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903505,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.29%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1028.05%、98.18%、48.89%，振幅较大的相关个股有Vaxcyte, Inc.、Fate Therapeutics, Inc.、Nurix Therapeutics, Inc.，振幅分别为107.85%、107.84%、106.06%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145a21d2a34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145a21d2a34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2481360756","title":"Zentalis Pharmaceuticals Inc    预计每股亏损 91 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481360756","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481360756?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:09","pubTimestamp":1730902141,"startTime":"0","endTime":"0","summary":"   * Zentalis Pharmaceuticals Inc    将于11月8日公布截至2024年9月30日的财报() 预计该公司的季度收入将保持不变。*    * LSEG分析师对Zentalis Pharmaceuticals Inc的平均预期是每股亏损91美分。* 华尔街对 Zentalis Pharmaceuticals Inc 的 12 个月目标价中位数为 8.00 美元，高于其上次收盘价 3.78 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Zentalis Pharmaceuticals Inc    预计每股亏损 91 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZNTL"],"gpt_icon":0},{"id":"2481688066","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481688066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481688066?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:34","pubTimestamp":1730817284,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时34分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.09%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223444aba23d08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223444aba23d08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2480581759","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.12%报3.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581759?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:34","pubTimestamp":1730730867,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时34分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.12%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为236.20%、138.54%、44.54%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为29.83%、22.67%、13.75%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223427ab9ebf86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223427ab9ebf86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2480777882","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.13%报2.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480777882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480777882?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:23","pubTimestamp":1730470982,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时23分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.13%。截至发稿，该股报2.87美元/股，成交量17.0113万股，换手率0.24%，振幅5.86%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122230395bdabe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122230395bdabe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2480881592","title":"Zentalis Pharmaceuticals Inc    预计每股亏损 91 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480881592","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480881592?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:58","pubTimestamp":1730469502,"startTime":"0","endTime":"0","summary":"   * Zentalis Pharmaceuticals Inc    将于11月4日公布截至2024年9月30日的财报() 预计该公司的季度收入将保持不变。*    * LSEG分析师对Zentalis Pharmaceuticals Inc的平均预期是每股亏损91美分。* 华尔街对 Zentalis Pharmaceuticals Inc 的 12 个月目标价中位数为 8.00 美元，高于其最新收盘价 2.73 美元。11月1日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Zentalis Pharmaceuticals Inc    预计每股亏损 91 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZNTL"],"gpt_icon":0},{"id":"2479036095","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.00%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479036095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479036095?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:26","pubTimestamp":1730384771,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时26分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.00%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.13%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Karyopharm Therapeutics Inc.、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Aditxt, Inc.、Evogene Ltd.、Palisade Bio, Inc.较为活跃，换手率分别为233.78%、226.79%、158.71%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Cingulate Inc C/Wts 10/12/2026 、Vaccinex, Inc.，振幅分别为45.05%、39.30%、37.72%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122261298e3fbf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122261298e3fbf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2478481443","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.30%报2.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478481443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478481443?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:56","pubTimestamp":1730123760,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时56分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.30%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215600a1f25aef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215600a1f25aef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2478682049","title":"Zentalis Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.00%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478682049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478682049?lang=zh_cn&edition=full","pubTime":"2024-10-26 03:04","pubTimestamp":1729883064,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日03时04分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.00%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为858.04%、790.10%、404.85%，振幅较大的相关个股有Iterum Therapeutics Plc、Elevai Labs, Inc.、Qualigen Therapeutics, Inc.，振幅分别为102.56%、93.82%、91.58%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026030424971a2632&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026030424971a2632&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2477362566","title":"Zentalis Pharmaceuticals, Inc.盘中异动 下午盘急速拉升5.06%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477362566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477362566?lang=zh_cn&edition=full","pubTime":"2024-10-24 03:27","pubTimestamp":1729711643,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日03时27分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.06%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.48%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024032723971a1df8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024032723971a1df8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2476216471","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.00%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476216471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476216471?lang=zh_cn&edition=full","pubTime":"2024-10-19 04:00","pubTimestamp":1729281646,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日04时00分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.00%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Biovie Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，180 Life Sciences Corp.、Quoin Pharmaceuticals Ltd、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1653.06%、1018.38%、662.44%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Biovie Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为255.36%、159.82%、113.50%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019040047971a12e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019040047971a12e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2473105153","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.04%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473105153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473105153?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:32","pubTimestamp":1728307948,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时32分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.04%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Scholar Rock Holding Corporation、Ibio, Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Aditxt, Inc.、Phio Pharmaceuticals Corp.、Elevai Labs, Inc.较为活跃，换手率分别为533.96%、47.74%、10.47%，振幅较大的相关个股有Scholar Rock Holding Corporation、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Renovaro Inc.，振幅分别为31.81%、18.44%、9.50%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721322998e3ad7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721322998e3ad7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2473999922","title":"Zentalis Pharmaceuticals, Inc.盘中异动 下午盘急速拉升5.16%报3.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473999922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473999922?lang=zh_cn&edition=full","pubTime":"2024-10-05 03:06","pubTimestamp":1728068808,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日03时06分，Zentalis Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.16%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Entero Therapeutics Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Cue Biopharma, Inc.涨幅较大，Aditxt, Inc.、Seelos Therapeutics, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为17605.05%、95.79%、79.19%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为103.24%、69.59%、58.64%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100503064898e3aa73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100503064898e3aa73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2472579403","title":"Zentalis Pharmaceuticals, Inc.盘中异动 大幅跳水5.04%报3.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472579403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472579403?lang=zh_cn&edition=full","pubTime":"2024-10-03 00:51","pubTimestamp":1727887883,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日00时51分，Zentalis Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.04%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Aditxt, Inc.、Windtree Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1105.57%、54.68%、50.79%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Apollomics Inc C/Wts 01/04/2028 、Aditxt, Inc.，振幅分别为145.55%、60.44%、51.53%。Zentalis Pharmaceuticals, Inc.公司简介：Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100300512498e3a3e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100300512498e3a3e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zentalis.com","stockEarnings":[{"period":"1week","weight":-0.1237},{"period":"1month","weight":0.1644},{"period":"3month","weight":0.1086},{"period":"6month","weight":-0.7125},{"period":"1year","weight":-0.6907},{"period":"ytd","weight":-0.771}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zentalis Pharmaceuticals, Inc.于2014年12月23日在特拉华州以Zeno Pharmaceuticals，Inc.的身份注册成立。Zentalis Pharmaceuticals，Inc.是一家临床阶段制药公司，致力于发现和开发针对癌症基本生物途径的临床分化的新型小分子疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.157062},{"month":2,"riseRate":0.5,"avgChangeRate":0.007508},{"month":3,"riseRate":0.5,"avgChangeRate":-0.019358},{"month":4,"riseRate":0.5,"avgChangeRate":-0.018876},{"month":5,"riseRate":0.6,"avgChangeRate":0.118909},{"month":6,"riseRate":0.4,"avgChangeRate":-0.106955},{"month":7,"riseRate":0.4,"avgChangeRate":-0.068858},{"month":8,"riseRate":0.2,"avgChangeRate":0.016639},{"month":9,"riseRate":0.2,"avgChangeRate":-0.089748},{"month":10,"riseRate":0.6,"avgChangeRate":0.026783},{"month":11,"riseRate":0.6,"avgChangeRate":0.02951},{"month":12,"riseRate":0.75,"avgChangeRate":0.075221}],"exchange":"NASDAQ","name":"Zentalis Pharmaceuticals, LLC","nameEN":"Zentalis Pharmaceuticals, LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zentalis Pharmaceuticals, LLC(ZNTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zentalis Pharmaceuticals, LLC(ZNTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zentalis Pharmaceuticals, LLC,ZNTL,Zentalis Pharmaceuticals, LLC股票,Zentalis Pharmaceuticals, LLC股票老虎,Zentalis Pharmaceuticals, LLC股票老虎国际,Zentalis Pharmaceuticals, LLC行情,Zentalis Pharmaceuticals, LLC股票行情,Zentalis Pharmaceuticals, LLC股价,Zentalis Pharmaceuticals, LLC股市,Zentalis Pharmaceuticals, LLC股票价格,Zentalis Pharmaceuticals, LLC股票交易,Zentalis Pharmaceuticals, LLC股票购买,Zentalis Pharmaceuticals, LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zentalis Pharmaceuticals, LLC(ZNTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zentalis Pharmaceuticals, LLC(ZNTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}